VIVO - If The COVID-19 Delta Variant Spreads This Fall Meridian Is Still A Buy
- A rapid increase in Delta variant spread in the world may be good news for Meridian's testing supply business.
- Meridian valuations are discounting the end of the U.S. pandemic this summer, which is far from certain going into the autumn.
- A sizable short interest position has been built in the first half of 2021, betting on a quick end to the pandemic globally.
- Delta's ability to wreak havoc in the lives of unvaccinated individuals and society at large is little understood in early July.
For further details see:
If The COVID-19 Delta Variant Spreads This Fall, Meridian Is Still A Buy